Award

Delivery Order #SPE2DR26F9WF8

Delivery Order for Ondansetron Tablets Under Long-Term Pharmaceutical Contract

Buyer

Defense Logistics Agency

Award Amount

$17,670.71

Ceiling

$17,670.71

Awarded

March 16, 2026

Period of Performance

Mar 16, 2026 – Mar 17, 2026

Identifier

SPE2DR26F9WF8

NAICS

424210

This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, under the umbrella of an existing long-term indefinite delivery vehicle contract. The contract specifically pertains to the procurement of Ondansetron HCL 4 mg tablets, a medication commonly used to prevent nausea and vomiting in healthcare settings. The significance of this award lies in its support for critical medication supply, ensuring timely availability for patient care. The scope of work covers the delivery of specified quantities of this pharmaceutical product to a designated location in Conshohocken, Pennsylvania. This delivery order follows a competitive procurement process structured within the larger indefinite delivery contract, allowing for flexible and continuous acquisition of necessary pharmaceuticals. The contract is set for a brief performance period, emphasizing prompt fulfillment. The original solicitation is part of a broader program to enhance pharmaceutical product distribution, with AmerisourceBergen's ongoing performance reinforcing the agency's capacity to maintain an efficient healthcare supply chain.

Description

4571167372!ONDANSETRON HCL 4 MG TABLET 500S

View original record